These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15604243)

  • 1. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma.
    Planagumà J; Díaz-Fuertes M; Gil-Moreno A; Abal M; Monge M; García A; Baró T; Thomson TM; Xercavins J; Alameda F; Reventós J
    Cancer Res; 2004 Dec; 64(24):8846-53. PubMed ID: 15604243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma.
    Planagumà J; Abal M; Gil-Moreno A; Díaz-Fuertes M; Monge M; García A; Baró T; Xercavins J; Reventós J; Alameda F
    J Pathol; 2005 Dec; 207(4):422-9. PubMed ID: 16175655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The up-regulation profiles of p21WAF1/CIP1 and RUNX1/AML1 correlate with myometrial infiltration in endometrioid endometrial carcinoma.
    Planagumà J; Gonzalez M; Doll A; Monge M; Gil-Moreno A; Baró T; García A; Xercavins J; Alameda F; Abal M; Reventós J
    Hum Pathol; 2006 Aug; 37(8):1050-7. PubMed ID: 16867868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERM/ETV5 and RUNX1/AML1 expression in endometrioid adenocarcinomas of endometrium and association with neoplastic progression.
    de Sousa VP; Chaves CB; Huguenin JF; Moreira FC; de Reis BS; Chimelli L; Bergmann A; Simão Tde A; Pinto LF
    Cancer Biol Ther; 2014 Jul; 15(7):888-94. PubMed ID: 24756106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma.
    Planagumà J; Liljeström M; Alameda F; Bützow R; Virtanen I; Reventós J; Hukkanen M
    Hum Pathol; 2011 Jan; 42(1):57-67. PubMed ID: 20970160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
    He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
    Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
    Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma.
    Mozos A; Catasús L; D'Angelo E; Serrano E; Espinosa I; Ferrer I; Pons C; Prat J
    Hum Pathol; 2014 May; 45(5):942-51. PubMed ID: 24746199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
    Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression.
    Westin SN; Broaddus RR; Deng L; McCampbell A; Lu KH; Lacour RA; Milam MR; Urbauer DL; Mueller P; Pickar JH; Loose DS
    Cancer Biol Ther; 2009 Nov; 8(22):2126-35. PubMed ID: 19755863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors.
    Abal M; Planaguma J; Gil-Moreno A; Monge M; Gonzalez M; Baro T; Garcia A; Castellvi J; Ramon Y Cajal S; Xercavins J; Alameda F; Reventos J
    Histol Histopathol; 2006 Feb; 21(2):197-204. PubMed ID: 16329044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma.
    Yang Y; Jiang Y; Jiang M; Zhang J; Yang B; She Y; Wang W; Deng Y; Ye Y
    Exp Mol Pathol; 2016 Apr; 100(2):344-52. PubMed ID: 26970279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential gene expression profile reveals overexpression of MAP3K8 in invasive endometrioid carcinoma.
    Aparecida Alves C; Silva ID; Villanova FE; Nicolau SM; Custódio MA; Bortoletto C; Gonçalves WJ
    Eur J Gynaecol Oncol; 2006; 27(6):589-93. PubMed ID: 17290588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isomorph expression of BAG-1 gene, ER and PR in endometrial cancer.
    Porichi O; Nikolaidou ME; Apostolaki A; Arnogiannaki N; Papassideri I; Chatonidis I; Tserkezoglou A; Vorgias G; Kassanos D; Panotopoulou E
    Anticancer Res; 2010 Oct; 30(10):4103-8. PubMed ID: 21036726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
    Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
    Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma.
    Yang Y; Zhou L; Lu L; Wang L; Li X; Jiang P; Chan LK; Zhang T; Yu J; Kwong J; Cheung TH; Chung T; Mak K; Sun H; Wang H
    Oncogene; 2013 Jul; 32(29):3432-42. PubMed ID: 22907428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients.
    Huang CY; Chang MC; Huang WY; Huang CT; Tang YC; Huang HD; Kuo KT; Chen CA; Cheng WF
    Sci Rep; 2015 Jun; 5():10680. PubMed ID: 26033187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer.
    Monge M; Colas E; Doll A; Gonzalez M; Gil-Moreno A; Planaguma J; Quiles M; Arbos MA; Garcia A; Castellvi J; Llaurado M; Rigau M; Alazzouzi H; Xercavins J; Alameda F; Reventos J; Abal M
    Cancer Res; 2007 Jul; 67(14):6753-9. PubMed ID: 17638886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
    Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
    Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.